Adverse events (AE) by trial arm.
| No. AE Per Participant | Trial Arm, n | Total Participants, n | ||
|---|---|---|---|---|
| Lead-in | 25 mg | 50 mg | ||
| 0 | 11 | 1 | 0 | 12 |
| 1–5 | 8 | 7 | 9 | 24 |
| 6–10 | 3 | 7 | 5 | 15 |
| 11–15 | 2 | 2 | 2 | 6 |
| 16–20 | 0 | 1 | 0 | 1 |
| 21+ | 0 | 1 | 0 | 1 |
| Total | 24 | 19 | 16 | 59 |
| AE | Trial Arm, n | ||
|---|---|---|---|
| Lead-in | 25 mg | 50 mg | |
| Infectious complications | 4 | 30 | 21 |
| Injection site reaction | 5 | 16 | 9 |
| Itching/skin rash | 1 | 4 | 1 |
| Uveitis | 2 | 3 | 0 |